{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:42:05Z","timestamp":1788280925674,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05053-z","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:34:55Z","timestamp":1770892495000},"page":"3029-3038","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transperineal cognitive versus trans-rectal fusion biopsy under local anesthesia: multicenter outcomes in detection rates, complications, and feasibility"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8319-512X","authenticated-orcid":false,"given":"Ekrem","family":"Ba\u015faran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9520-5644","authenticated-orcid":false,"given":"\u0130smail Ey\u00fcp","family":"Dilek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4556-3475","authenticated-orcid":false,"given":"Arda Ta\u015fk\u0131n","family":"Ta\u015fk\u0131ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8051-5802","authenticated-orcid":false,"given":"Ahmet Y\u0131ld\u0131r\u0131m","family":"Bal\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6954-709X","authenticated-orcid":false,"given":"Muhammed Z\u00fcbeyr","family":"Canbolat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8157-6314","authenticated-orcid":false,"given":"Abdullah","family":"\u00c7ay\u0131rl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2325-5141","authenticated-orcid":false,"given":"Serhat Haluk","family":"\u00dcnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1770-5165","authenticated-orcid":false,"given":"Halil","family":"Ba\u015fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2360-788X","authenticated-orcid":false,"given":"Erdem","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"2","key":"5053_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O, Bray F, Brawley O, Luckenbaugh AN, Mucci L et al (2023) 2022 update on prostate cancer epidemiology and risk factors-a systematic review. Eur Urol 84(2):191\u2013206","journal-title":"Eur Urol"},{"key":"5053_CR2","unstructured":"Leslie SW, Soon-Sutton TL, Skelton WP 2025 Prostate cancer. In: StatPearls. edn. Treasure Island (FL) ineligible companies. Disclosure: Taylor Soon-Sutton declares no relevant financial relationships with ineligible companies. Disclosure: William Skelton declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC."},{"key":"5053_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/diseases13060167","author":"Z Dushimova","year":"2025","unstructured":"Dushimova Z, Iztleuov Y, Chingayeva G (2025) Overdiagnosis and overtreatment in prostate cancer. Dis. https:\/\/doi.org\/10.3390\/diseases13060167","journal-title":"Dis"},{"issue":"3","key":"5053_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/2090598X.2022.2067615","volume":"20","author":"A Nowier","year":"2022","unstructured":"Nowier A, Mazhar H, Salah R, Shabayek M (2022) Performance of multi-parametric magnetic resonance imaging through PIRADS scoring system in biopsy na\u00efve patients with suspicious prostate cancer. Arab J Urol 20(3):121\u2013125","journal-title":"Arab J Urol"},{"key":"5053_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.euros.2025.03.006","volume":"75","author":"TF Soeterik","year":"2025","unstructured":"Soeterik TF, Wu X, den Van Bergh RC, Kesch C, Zattoni F, Falagario U, Martini A, Miszczyk M, Fasulo V, Maggi M (2025) Personalised prostate cancer diagnosis: evaluating biomarker-based approaches to reduce unnecessary magnetic resonance imaging and biopsy procedures. Eur Urol Open Sci 75:106\u2013119","journal-title":"Eur Urol Open Sci"},{"issue":"4","key":"5053_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.21037\/tau-2024-754","volume":"14","author":"M Hsu","year":"2025","unstructured":"Hsu M, Sekoulopoulos S, Raman JD (2025) Choosing the path: insights into transperineal vs. transrectal prostate biopsy. Transl Androl Urol 14(4):883\u2013887","journal-title":"Transl Androl Urol"},{"key":"5053_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2025.07.017","author":"E Suzman","year":"2025","unstructured":"Suzman E, Malik Wahba B, Wald G, Kaneria A, Hu JC (2025) Review of transperineal and transrectal prostate biopsy outcomes. Eur Urol Focus. https:\/\/doi.org\/10.1016\/j.euf.2025.07.017","journal-title":"Eur Urol Focus"},{"issue":"2","key":"5053_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, Eberli D, De Meerleer G, De Santis M, Farolfi A et al (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol 86(2):148\u2013163","journal-title":"Eur Urol"},{"issue":"4","key":"5053_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-016-0589-z","volume":"17","author":"M Kongnyuy","year":"2016","unstructured":"Kongnyuy M, George AK, Rastinehad AR, Pinto PA (2016) Magnetic resonance imaging-ultrasound fusion-guided prostate biopsy: review of technology, techniques, and outcomes. Curr Urol Rep 17(4):32","journal-title":"Curr Urol Rep"},{"issue":"61","key":"5053_CR10","first-page":"1","volume":"28","author":"A Llewellyn","year":"2024","unstructured":"Llewellyn A, Phung TH (2024) MRI software and cognitive fusion biopsies in people with suspected prostate cancer: a systematic review, network meta-analysis and cost-effectiveness analysis. Heal Tech Asses (Winchester, England) 28(61):1\u2013310","journal-title":"Heal Tech Asses (Winchester, England)"},{"issue":"1","key":"5053_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-024-05245-1","volume":"42","author":"M Oderda","year":"2024","unstructured":"Oderda M, Diamand R, Abou Zahr R, Anract J, Assenmacher G, Barry Delongchamps N, Bui AP, Benamran D, Calleris G, Dariane C et al (2024) Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complications. World J Urol 42(1):535","journal-title":"World J Urol"},{"issue":"14","key":"5053_CR12","doi-asserted-by":"publisher","first-page":"23322","DOI":"10.18632\/oncotarget.15056","volume":"8","author":"J Xue","year":"2017","unstructured":"Xue J, Qin Z, Cai H, Zhang C, Li X, Xu W, Wang J, Xu Z, Yu B, Xu T et al (2017) Comparison between transrectal and transperineal prostate biopsy for detection of prostate cancer: a meta-analysis and trial sequential analysis. Oncotarget 8(14):23322\u201323336","journal-title":"Oncotarget"},{"issue":"4","key":"5053_CR13","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.eururo.2018.11.040","volume":"75","author":"O Wegelin","year":"2019","unstructured":"Wegelin O, Exterkate L, van der Leest M, Kummer JA, Vreuls W, de Bruin PC, Bosch JR, Barentsz JO, Somford DM, van Melick HH (2019) The FUTURE trial: a multicenter randomised controlled trial on target biopsy techniques based on magnetic resonance imaging in the diagnosis of prostate cancer in patients with prior negative biopsies. Eur Urol 75(4):582\u2013590","journal-title":"Eur Urol"},{"issue":"1","key":"5053_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-022-00453-7","volume":"22","author":"S Lewis","year":"2022","unstructured":"Lewis S, Ganti A, Argiriadi P, Rosen A, Hectors S, Semaan S, Song C, Peti S, Segall M, George K et al (2022) Prostate MRI using a rigid two-channel phased-array endorectal coil: comparison with phased array coil acquisition at 3\u2009T. Cancer Imaging 22(1):15","journal-title":"Cancer Imaging"},{"issue":"11","key":"5053_CR15","doi-asserted-by":"publisher","first-page":"E523","DOI":"10.5489\/cuaj.7781","volume":"16","author":"M Brassil","year":"2022","unstructured":"Brassil M, Li Y, Ordon M, Colak E, Vlachou P (2022) Infection complications after transrectal ultrasound-guided prostate biopsy: a radiology department\u2019s experience and strategy for improvement. Can Urol Assoc J 16(11):E523-e527","journal-title":"Can Urol Assoc J"},{"issue":"6","key":"5053_CR16","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.21037\/tau.2019.12.40","volume":"9","author":"A Thomson","year":"2020","unstructured":"Thomson A, Li M, Grummet J, Sengupta S (2020) Transperineal prostate biopsy: a review of technique. Transl Androl Urol 9(6):3009\u20133017","journal-title":"Transl Androl Urol"},{"issue":"8","key":"5053_CR17","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","volume":"44","author":"G van Leenders","year":"2020","unstructured":"van Leenders G, van der Kwast TH, Grignon DJ, Evans AJ, Kristiansen G, Kweldam CF, Litjens G, McKenney JK, Melamed J, Mottet N et al (2020) The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma. Am J Surg Pathol 44(8):e87\u2013e99","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"5053_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00345-024-05000-6","volume":"42","author":"G Duwe","year":"2024","unstructured":"Duwe G, Schmitteckert M, Haack M, Sparwasser P, Dotzauer R, Thomas A, Tsaur I, Brandt MP, Kurosch M, Mager R et al (2024) Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study. World J Urol 42(1):297","journal-title":"World J Urol"},{"issue":"1","key":"5053_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14203-y","volume":"25","author":"Y Huang","year":"2025","unstructured":"Huang Y, Wei C, Chen F, Zhang Y, Pu F (2025) Comparing the biopsy strategies of prostate cancer: a systematic review and network meta-analysis. BMC Cancer 25(1):786","journal-title":"BMC Cancer"},{"issue":"1","key":"5053_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12894-019-0539-4","volume":"19","author":"GL Huang","year":"2019","unstructured":"Huang GL, Kang CH, Lee WC, Chiang PH (2019) Comparisons of cancer detection rate and complications between transrectal and transperineal prostate biopsy approaches - a single center preliminary study. BMC Urol 19(1):101","journal-title":"BMC Urol"},{"issue":"1","key":"5053_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4274\/uob.galenos.2020.1686","volume":"20","author":"O Akyuz","year":"2021","unstructured":"Akyuz O, Ergun M, Bodakci MN, Deniz E, Kilic B, Coban S, Cakir SS, Tefekli AH (2021) Comparison of prostate cancer detection rates of cognitive fusion-targeted biopsy and standard transrectal ultrasound-guided biopsy. Bull Urooncol 20(1):15\u201319","journal-title":"Bull Urooncol"},{"key":"5053_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061449","author":"D Sugano","year":"2021","unstructured":"Sugano D, Kaneko M, Yip W (2021) Comparative effectiveness of techniques in targeted prostate biopsy. Cancers. https:\/\/doi.org\/10.3390\/cancers13061449","journal-title":"Cancers"},{"key":"5053_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.urology.2023.11.039","volume":"186","author":"M Hung","year":"2024","unstructured":"Hung M, Ross AE, Li EV, Pavlovich CP, Fletcher SA, Gereta S, Zhang TR, McClure TD, Allaf ME, Schaeffer EM et al (2024) Prostate cancer detection rate of transperineal prostate biopsy: cognitive vs software fusion, a multicenter analysis. Urology 186:91\u201397","journal-title":"Urology"},{"key":"5053_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17132206","author":"F Carletti","year":"2025","unstructured":"Carletti F, Reitano G, Toffoletto EM, Tumminello A, Tonet E, Basso G, Bruniera M (2025) Detection rates of prostate cancer across prostatic zones using freehand single-access transperineal fusion biopsies. Cancers. https:\/\/doi.org\/10.3390\/cancers17132206","journal-title":"Cancers"},{"issue":"17","key":"5053_CR25","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.3390\/cancers14174161","volume":"14","author":"L Blas","year":"2022","unstructured":"Blas L, Shiota M, Eto M (2022) Active surveillance in intermediate-risk prostate cancer: a review of the current data. Cancers 14(17):4161","journal-title":"Cancers"},{"key":"5053_CR26","volume":"82","author":"Q Wu","year":"2025","unstructured":"Wu Q, Wang J, Tu X, Chen B, Jiang J, Ye J, Zheng L, He C, Tang B, Bao Y et al (2025) Optimizing the strategies to perform prostate biopsy in MRI-positive patients: a systematic review and network meta-analysis. EClinMed 82:103164","journal-title":"EClinMed"},{"issue":"4","key":"5053_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/pros.24832","volume":"85","author":"A Orsini","year":"2025","unstructured":"Orsini A, Ferretti S, Porreca A, Castellan P, Litterio G, Ciavarella D, De Palma A, Berardinelli F, Pizzi AD, D\u2019Angelo E et al (2025) PI-RADS in predicting csPCa: a comparison between academic and nonacademic centers. Prostate 85(4):337\u2013343","journal-title":"Prostate"},{"issue":"18","key":"5053_CR28","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1002\/cncr.34355","volume":"128","author":"AM Fang","year":"2022","unstructured":"Fang AM, Shumaker LA, Martin KD, Jackson JC, Fan RE, Khajir G, Patel HD (2022) Multi-institutional analysis of clinical and imaging risk factors for detecting clinically significant prostate cancer in men with PI-RADS 3 lesions. Cancer 128(18):3287\u20133296","journal-title":"Cancer"},{"issue":"1","key":"5053_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03742-z","volume":"22","author":"R Deng","year":"2024","unstructured":"Deng R, Liu Y, Wang K, Ruan M, Li D, Wu J, Qiu J, Wu P, Tian P, Yu C et al (2024) Comparison of MRI artificial intelligence-guided cognitive fusion-targeted biopsy versus routine cognitive fusion-targeted prostate biopsy in prostate cancer diagnosis: a randomized controlled trial. BMC Med 22(1):530","journal-title":"BMC Med"},{"key":"5053_CR30","doi-asserted-by":"publisher","DOI":"10.4274\/uob.galenos.2024.2023.11.3","author":"T \u00c7etin","year":"2024","unstructured":"\u00c7etin T, \u00c7elik S, S\u00fcer E, S\u00f6zen S, \u0130zol V, Akdo\u011fan B, T\u00fcrkeri L, Aslan G, \u00d6zen H, \u015eahin B (2024) Do subgroup evaluations provide additional contributions to biochemical recurrence in grade group 4 and 5 patients? A multicenter study by the Turkish Urooncology Association Prostate Cancer Working Group. Bulletin Uroncol. https:\/\/doi.org\/10.4274\/uob.galenos.2024.2023.11.3","journal-title":"Bulletin Uroncol"},{"issue":"1","key":"5053_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.prnil.2023.11.002","volume":"12","author":"S Gatsos","year":"2024","unstructured":"Gatsos S, Kalogeras N, Dimakopoulos G, Samarinas M, Papakonstantinou A, Petinaki E, Tzortzis V, Gravas S (2024) Infectious complications of transrectal prostate biopsy in patients receiving targeted antibiotic prophylaxis after urethral and rectal swab versus standard prophylaxis: a prospective comparative study. Prostate Int 12(1):35\u201339","journal-title":"Prostate Int"},{"issue":"6","key":"5053_CR32","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1089\/sur.2015.040","volume":"16","author":"L Yang","year":"2015","unstructured":"Yang L, Gao L, Chen Y, Tang Z, Liu L, Han P, Zeng H, Li X, Wei Q (2015) Prophylactic antibiotics in prostate biopsy: a meta-analysis based on randomized controlled trials. Surg Infect 16(6):733\u2013747","journal-title":"Surg Infect"},{"issue":"4","key":"5053_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4103\/iju.iju_36_24","volume":"40","author":"S Agrawal","year":"2024","unstructured":"Agrawal S, Patil VD, Prasad V, Menon AR, Pooleri GK (2024) Factors influencing urinary retention following freehand transperineal prostate biopsy: insights from a tertiary care center study. Indian J Urol 40(4):229\u2013234","journal-title":"Indian J Urol"},{"issue":"7","key":"5053_CR34","first-page":"E350","volume":"16","author":"Z Kozel","year":"2022","unstructured":"Kozel Z, Martin C, Mikhail D, Smith A, Griffiths L, Nethala D, Vira M, Schwartz M (2022) Initial experience and cancer detection rates of office-based transperineal magnetic resonance imaging-ultrasound fusion prostate biopsy under local anesthesia. Canadian Urolog Assoc J J de l\u2019Association des urologues du Canada 16(7):E350-e356","journal-title":"Canadian Urolog Assoc J J de l'Association des urologues du Canada"},{"issue":"6","key":"5053_CR35","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/ans.17593","volume":"92","author":"A Hong","year":"2022","unstructured":"Hong A, Hemmingway S, Wetherell D, Dias B, Zargar H (2022) Outpatient transperineal prostate biopsy under local anaesthesia is safe, well tolerated and feasible. ANZ J Surg 92(6):1480\u20131485","journal-title":"ANZ J Surg"},{"issue":"4","key":"5053_CR36","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s41669-021-00277-4","volume":"5","author":"ECF Wilson","year":"2021","unstructured":"Wilson ECF, Wreford A, Tamer P, Leonard K, Brechka H, Gnanapragasam VJ (2021) Economic evaluation of transperineal versus transrectal devices for local anaesthetic prostate biopsies. PharmacoEconomics - open 5(4):737\u2013753","journal-title":"PharmacoEconomics - open"},{"issue":"60","key":"5053_CR37","first-page":"1","volume":"28","author":"I Souto-Ribeiro","year":"2024","unstructured":"Souto-Ribeiro I, Woods L, Maund E, Scott DA, Lord J, Picot J, Shepherd J (2024) Transperineal biopsy devices in people with suspected prostate cancer-a systematic review and economic evaluation. Heal Techn Assess (Winchester, England) 28(60):1","journal-title":"Heal Techn Assess (Winchester, England)"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05053-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05053-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05053-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:19:14Z","timestamp":1784193554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05053-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["5053"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05053-z","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki, and approved by the Non-Interventional Clinical Research Ethics Committee of Duzce University (protocol code 2025\/144, approved on 02 June 2025.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient consent was waived due to the retrospective nature of the study and the use of anonymized data.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}